Sign In
Manage PermissionsManage Permissions

Six Types of Health Products Found To Be Adulterated

Health Products Found Adulterated

 

The Ministry of Health would like to alert members of the public to six types of health products which have been tested by the Pharmacy Section, Department of Scientific Services, Ministry of Health and found to be adulterated with undeclared, potent western medicines.

                                     

The affected health products are listed as below:                                 

 

No.Name of productManufacturerAdulterated with
1.Jus Al Sunnah Gold 1001 Khasiat Jus Alternatif Sri Saga Marketing S/B, MalaysiaDexamethasone
2.

Jus Al Sunnah 1001 Khasiat

Jus Alternatif

Sri Saga Marketing S/B, MalaysiaDexamethasone
3.Jus Penawar 1001 Khasiat Jus Alternatif ResdungSri Saga Marketing S/B, Malaysia

Dexamethasone,

Chlorpheniramine

4.Herba Saraf PilReshoon MarketingDexamethasone
5.Proven Capsule 350mgFranceSibutramine & Phenolphthalein
6.Royal Café Power DrinkRoyalife International Sdn Bhd, MalaysiaPhenolphthalein

 

Pictures of products:

 

Jus Al Sunnah Gold 1001 Khasiat Jus Alternatif

 

 Jus Al Sunnah 1001 Khasiat Jus Alternatif

 

Jus Penawar 1001 Khasiat Jus Alternatif Resdung

 

Herba Saraf Pil


Proven Capsule 350mg

 

Royal Café Power Drink


The adulterants found in these products can cause adverse effects that are potentially hazardous to the people using them.

 

Unsupervised long-term consumption of potent corticosteroids such as Dexamethasone can cause increase blood glucose levels leading to diabetes, high blood pressure, cataract, muscular and bone disorders, and an increased risk of infections. Long term use of corticosteroids can also lead to Cushing's syndrome which is characterized by a round face or 'moon face', and upper body obesity with thin limbs. Consumers who have taken high doses of steroids over a prolonged period of time may suffer from withdrawal symptoms which include fatigue, muscle and joint pain, fever, low blood sugar, low blood pressure and dehydration.

 

Dizziness, lowering of blood pressure, irregular heartbeat, confusion, depression and convulsions are among the adverse effects that could occur from the unsupervised consumption of Chlorpheniramine.

 

Sibutramine is a body slimming agent that is no longer recommended for its use in obesity treatment because its effects can be detrimental to the heart and the liver. Intake sibutramine can also cause serious adverse effects such as high blood pressure, uncertain heartbeat and difficulty sleeping; and regards the worst cases, it can cause damage to the kidneys and liver.

 

Prolonged consumption or overdose of Phenolphthalein can result in diarrhoea with excessive loss of water and electrolytes, and there is also the possibility of developing an atonic non-functioning colon. Cardiac and respiratory distress, renal damage and hypersensitivity reactions have also been reported with the use of this drug.

 

The Ministry of Health has not issued any approval for the importation for the sale of these products. Following these findings, the products are not allowed to be imported and sold in Brunei Darussalam.

 

Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.

 

Members of the public involved in the retail of these products (including online retail such as through Facebook, etc.) are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months' imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months' imprisonment.

 

The Ministry of Health would also like to call upon the public for their cooperation to report to the Pharmacy Enforcement Section if any of these products are still found on the market in this country.

 

For further information and communication, the public may contact the Pharmacy Enforcement Section at 2393298 extension 208; send an e-mail to pharmacy.enforcement@moh.gov.bn; go directly to 1st Floor, Department of Pharmaceutical Services' Building, Kg. Madaras, Mukim Gadong A; or call the Talian Darussalam 123.

 

 

- E N D -

 

Reference    : KK/PR/3

Date            : 9 June 2018 /24 Ramadhan 1439H

Attachments